{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:43:10Z","timestamp":1785253390195,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003945","name":"Link\u00f6ping University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003945","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>There is currently limited understanding of the relationship between copeptin, the midregional portion of proadrenomedullin (MRproADM) and the midregional fragment of the N-terminal of proatrial natriuretic peptide (MRproANP), and arterial disorders. Toe brachial index (TBI) and aortic pulse wave velocity (aPWV) are established parameters for detecting arterial disorders. This study evaluated whether copeptin, MRproADM, and MRproANP were associated with TBI and aPWV in patients with type 2 diabetes with no history of cardiovascular disease (CVD).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In the CARDIPP study, a cross-sectional analysis of 519 patients with type 2 diabetes aged 55\u201365 years with no history of CVD at baseline, had complete data on copeptin, MRproADM, MRproANP, TBI, and aPWV was performed. Linear regression analysis was used to investigate the associations between conventional CVD risk factors, copeptin, MRproADM, MRproANP, TBI, and aPWV.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Copeptin was associated with TBI (\u03b2\u20130.0020, CI\u20130.0035\u2013 (\u20130.0005), <jats:italic>p<\/jats:italic>\u2009=\u20090.010) and aPWV (\u03b2 0.023, CI 0.002\u20130.044, <jats:italic>p<\/jats:italic>\u2009=\u20090.035). These associations were independent of age, sex, diabetes duration, mean 24-hour ambulatory systolic blood pressure, glycated hemoglobin A1c, total cholesterol, estimated glomerular filtration rate, body mass index, and active smoking.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Plasma copeptin may be a helpful surrogate for identifying individuals at higher risk for arterial disorders.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial Registration:<\/jats:title>\n                <jats:p>\u00a0ClinicalTrials.gov identifier NCT010497377.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12933-024-02291-2","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T15:01:56Z","timestamp":1718204516000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Plasma copeptin and markers of arterial disorder in patients with type 2 diabetes, a cross-sectional study"],"prefix":"10.1186","volume":"23","author":[{"given":"Lee Ti","family":"Davidson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Engvall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona I.","family":"Chisalita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl Johan","family":"\u00d6stgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik H.","family":"Nystr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,12]]},"reference":[{"issue":"9901","key":"2291_CR1","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/s0140-6736(13)61249-0","volume":"382","author":"FG Fowkes","year":"2013","unstructured":"Fowkes FG, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382(9901):1329\u201340. https:\/\/doi.org\/10.1016\/s0140-6736(13)61249-0.","journal-title":"Lancet"},{"issue":"9","key":"2291_CR2","doi-asserted-by":"publisher","first-page":"921","DOI":"10.5551\/jat.39669","volume":"24","author":"E Nakamura","year":"2017","unstructured":"Nakamura E, Sato Y, Iwakiri T, Yamashita A, Moriguchi-Goto S, Maekawa K, et al. Asymptomatic plaques of Lower Peripheral Arteries and their Association with Cardiovascular Disease: an autopsy study. J Atheroscler Thromb. 2017;24(9):921\u20137. https:\/\/doi.org\/10.5551\/jat.39669.","journal-title":"J Atheroscler Thromb"},{"issue":"4","key":"2291_CR3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.5551\/jat.44891","volume":"26","author":"D Ozkaramanli Gur","year":"2019","unstructured":"Ozkaramanli Gur D, Gur O, Guzel S, Akyuz A, Gurkan S, Alpsoy S, et al. Inflammatory mediators across the Spectrum of Ankle-Brachial Index. J Atheroscler Thromb. 2019;26(4):351\u201361. https:\/\/doi.org\/10.5551\/jat.44891.","journal-title":"J Atheroscler Thromb"},{"key":"2291_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s40885-018-0102-8","volume":"24","author":"YS Oh","year":"2018","unstructured":"Oh YS. Arterial stiffness and hypertension. Clin Hypertens. 2018;24:17. https:\/\/doi.org\/10.1186\/s40885-018-0102-8.","journal-title":"Clin Hypertens"},{"issue":"19","key":"2291_CR5","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1093\/eurheartj\/ehq165","volume":"31","author":"Determinants of pulse","year":"2010","unstructured":"Determinants of pulse. Wave velocity in healthy people and in the presence of cardiovascular risk factors: \u2018establishing normal and reference values\u2019. Eur Heart J. 2010;31(19):2338\u201350. https:\/\/doi.org\/10.1093\/eurheartj\/ehq165.","journal-title":"Eur Heart J"},{"issue":"6","key":"2291_CR6","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1177\/00033197040550i605","volume":"55","author":"D Sahli","year":"2004","unstructured":"Sahli D, Eliasson B, Svensson M, Blohm\u00e9 G, Eliasson M, Samuelsson P, et al. Assessment of toe blood pressure is an effective screening method to identify diabetes patients with lower extremity arterial disease. Angiology. 2004;55(6):641\u201351. https:\/\/doi.org\/10.1177\/00033197040550i605.","journal-title":"Angiology"},{"key":"2291_CR7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.atherosclerosis.2020.09.026","volume":"315","author":"\u00c1 Herraiz-Adillo","year":"2020","unstructured":"Herraiz-Adillo \u00c1, Cavero-Redondo I, \u00c1lvarez-Bueno C, Pozuelo-Carrascosa DP, Solera-Mart\u00ednez M. The accuracy of toe brachial index and ankle brachial index in the diagnosis of lower limb peripheral arterial disease: a systematic review and meta-analysis. Atherosclerosis. 2020;315:81\u201392. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2020.09.026.","journal-title":"Atherosclerosis"},{"issue":"7","key":"2291_CR8","doi-asserted-by":"publisher","first-page":"647","DOI":"10.5551\/jat.29967","volume":"22","author":"T Koyama","year":"2015","unstructured":"Koyama T, Sakurai T, Kamiyoshi A, Ichikawa-Shindo Y, Kawate H, Shindo T. Adrenomedullin-RAMP2 system in vascular endothelial cells. J Atheroscler Thromb. 2015;22(7):647\u201353. https:\/\/doi.org\/10.5551\/jat.29967.","journal-title":"J Atheroscler Thromb"},{"issue":"17","key":"2291_CR9","doi-asserted-by":"publisher","first-page":"329","DOI":"10.21037\/atm.2016.08.65","volume":"4","author":"F Valenzuela-S\u00e1nchez","year":"2016","unstructured":"Valenzuela-S\u00e1nchez F, Valenzuela-M\u00e9ndez B, Rodr\u00edguez-Guti\u00e9rrez JF, Estella-Garc\u00eda \u00c1, Gonz\u00e1lez-Garc\u00eda M. New role of biomarkers: mid-regional pro-adrenomedullin, the biomarker of organ failure. Ann Transl Med. 2016;4(17):329. https:\/\/doi.org\/10.21037\/atm.2016.08.65.","journal-title":"Ann Transl Med"},{"issue":"6","key":"2291_CR10","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/joim.12756","volume":"283","author":"C Magnussen","year":"2018","unstructured":"Magnussen C, Blankenberg S. Biomarkers for heart failure: small molecules with high clinical relevance. J Intern Med. 2018;283(6):530\u201343. https:\/\/doi.org\/10.1111\/joim.12756.","journal-title":"J Intern Med"},{"issue":"11","key":"2291_CR11","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41569-020-0381-0","volume":"17","author":"JP Goetze","year":"2020","unstructured":"Goetze JP, Bruneau BG, Ramos HR, Ogawa T, de Bold MK, de Bold AJ. Cardiac natriuretic peptides. Nat Rev Cardiol. 2020;17(11):698\u2013717. https:\/\/doi.org\/10.1038\/s41569-020-0381-0.","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"2291_CR12","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1681\/asn.2010070691","volume":"22","author":"W Fenske","year":"2011","unstructured":"Fenske W, Wanner C, Allolio B, Drechsler C, Blouin K, Lilienthal J, et al. Copeptin levels associate with cardiovascular events in patients with ESRD and type 2 diabetes mellitus. J Am Soc Nephrology: JASN. 2011;22(4):782\u201390. https:\/\/doi.org\/10.1681\/asn.2010070691.","journal-title":"J Am Soc Nephrology: JASN"},{"issue":"5","key":"2291_CR13","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/j.ijcard.2012.12.039","volume":"167","author":"K Yalta","year":"2013","unstructured":"Yalta K, Yalta T, Sivri N, Yetkin E. Copeptin and cardiovascular disease: a review of a novel neurohormone. Int J Cardiol. 2013;167(5):1750\u20139. https:\/\/doi.org\/10.1016\/j.ijcard.2012.12.039.","journal-title":"Int J Cardiol"},{"issue":"9","key":"2291_CR14","doi-asserted-by":"publisher","first-page":"e22614","DOI":"10.1002\/jcla.22614","volume":"32","author":"A Koch","year":"2018","unstructured":"Koch A, Yagmur E, Hoss A, Buendgens L, Herbers U, Weiskirchen R, et al. Clinical relevance of copeptin plasma levels as a biomarker of disease severity and mortality in critically ill patients. J Clin Lab Anal. 2018;32(9):e22614. https:\/\/doi.org\/10.1002\/jcla.22614.","journal-title":"J Clin Lab Anal"},{"issue":"1","key":"2291_CR15","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12933-018-0753-5","volume":"17","author":"G Velho","year":"2018","unstructured":"Velho G, Ragot S, El Boustany R, Saulnier PJ, Fraty M, Mohammedi K, et al. Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes. Cardiovasc Diabetol. 2018;17(1):110. https:\/\/doi.org\/10.1186\/s12933-018-0753-5.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"2291_CR16","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00125-007-0918-3","volume":"51","author":"CD Stehouwer","year":"2008","unstructured":"Stehouwer CD, Henry RM, Ferreira I. Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Diabetologia. 2008;51(4):527\u201339. https:\/\/doi.org\/10.1007\/s00125-007-0918-3.","journal-title":"Diabetologia"},{"issue":"10","key":"2291_CR17","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.2337\/dc08-2168","volume":"32","author":"C Maier","year":"2009","unstructured":"Maier C, Clodi M, Neuhold S, Resl M, Elhenicky M, Prager R, et al. Endothelial markers may link kidney function to Cardiovascular events in type 2 diabetes. Diabetes Care. 2009;32(10):1890\u20135. https:\/\/doi.org\/10.2337\/dc08-2168.","journal-title":"Diabetes Care"},{"issue":"6","key":"2291_CR18","doi-asserted-by":"publisher","first-page":"e0128962","DOI":"10.1371\/journal.pone.0128962","volume":"10","author":"D Nilsson","year":"2015","unstructured":"Nilsson D, Sutton R, Tas W, Burri P, Melander O, Fedorowski A. Orthostatic changes in Hemodynamics and Cardiovascular biomarkers in dysautonomic patients. PLoS ONE. 2015;10(6):e0128962. https:\/\/doi.org\/10.1371\/journal.pone.0128962.","journal-title":"PLoS ONE"},{"key":"2291_CR19","doi-asserted-by":"publisher","unstructured":"Hamrefors V, Nilsson D, Melander O, Sutton R, Fedorowski A. Low Adrenomedullin and Endothelin-1 predict Cardioinhibitory Response during Vasovagal Reflex in adults over 40 years of age. Circ Arrhythm Electrophysiol. 2017;10(10). https:\/\/doi.org\/10.1161\/circep.117.005585.","DOI":"10.1161\/circep.117.005585"},{"issue":"4","key":"2291_CR20","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/MBP.0b013e328355fdfb","volume":"17","author":"M Wijkman","year":"2012","unstructured":"Wijkman M, L\u00e4nne T, Grodzinsky E, Ostgren CJ, Engvall J, Nystrom FH. Ambulatory systolic blood pressure predicts left ventricular mass in type 2 diabetes, independent of central systolic blood pressure. Blood Press Monit. 2012;17(4):139\u201344. https:\/\/doi.org\/10.1097\/MBP.0b013e328355fdfb.","journal-title":"Blood Press Monit"},{"issue":"2","key":"2291_CR21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.diabres.2013.03.004","volume":"100","author":"A Spangeus","year":"2013","unstructured":"Spangeus A, Wijkman M, Lindstrom T, Engvall JE, Ostgren CJ, Nystrom FH, et al. Toe brachial index in middle aged patients with diabetes mellitus type 2: not just a peripheral issue. Diabetes Res Clin Pract. 2013;100(2):195\u2013202. https:\/\/doi.org\/10.1016\/j.diabres.2013.03.004.","journal-title":"Diabetes Res Clin Pract"},{"issue":"7","key":"2291_CR22","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.jdiacomp.2016.06.008","volume":"30","author":"M Wijkman","year":"2016","unstructured":"Wijkman M, L\u00e4nne T, \u00d6stgren CJ, Nystrom FH. Aortic pulse wave velocity predicts incident cardiovascular events in patients with type 2 diabetes treated in primary care. J Diabetes Complicat. 2016;30(7):1223\u20138. https:\/\/doi.org\/10.1016\/j.jdiacomp.2016.06.008.","journal-title":"J Diabetes Complicat"},{"key":"2291_CR23","doi-asserted-by":"publisher","first-page":"108040","DOI":"10.1016\/j.diabres.2020.108040","volume":"161","author":"SI Chisalita","year":"2020","unstructured":"Chisalita SI, Wijkman M, Davidson LT, Sp\u00e5ngeus A, Nystr\u00f6m F, \u00d6stgren CJ. Toe brachial index predicts major acute cardiovascular events in patients with type 2 diabetes independently of arterial stiffness. Diabetes Res Clin Pract. 2020;161:108040. https:\/\/doi.org\/10.1016\/j.diabres.2020.108040.","journal-title":"Diabetes Res Clin Pract"},{"issue":"7","key":"2291_CR24","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1007\/s00125-010-1684-1","volume":"53","author":"RA DeFronzo","year":"2010","unstructured":"DeFronzo RA. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia. 2010;53(7):1270\u201387. https:\/\/doi.org\/10.1007\/s00125-010-1684-1.","journal-title":"Diabetologia"},{"issue":"7258","key":"2291_CR25","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","volume":"321","author":"IM Stratton","year":"2000","unstructured":"Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ (Clinical Res ed). 2000;321(7258):405\u201312.","journal-title":"BMJ (Clinical Res ed)"},{"issue":"7","key":"2291_CR26","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.2337\/dc10-0088","volume":"33","author":"LG Mellbin","year":"2010","unstructured":"Mellbin LG, Ryden L, Brismar K, Morgenthaler NG, Ohrvik J, Catrina SB, Copeptin. IGFBP-1, and cardiovascular prognosis in patients with type 2 diabetes and acute myocardial infarction: a report from the DIGAMI 2 trial. Diabetes Care. 2010;33(7):1604\u20136. https:\/\/doi.org\/10.2337\/dc10-0088.","journal-title":"Diabetes Care"},{"issue":"8","key":"2291_CR27","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1097\/HJH.0b013e3283613074","volume":"31","author":"AS Mansour","year":"2013","unstructured":"Mansour AS, Yannoutsos A, Majahalme N, Agnoletti D, Safar ME, Ouerdane S, et al. Aortic stiffness and cardiovascular risk in type 2 diabetes. J Hypertens. 2013;31(8):1584\u201392. https:\/\/doi.org\/10.1097\/HJH.0b013e3283613074.","journal-title":"J Hypertens"},{"issue":"6","key":"2291_CR28","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1177\/1479164114544464","volume":"11","author":"D Bar-Shalom","year":"2014","unstructured":"Bar-Shalom D, Poulsen MK, Rasmussen LM, Diederichsen AC, Sand NP, Henriksen JE, et al. Plasma copeptin as marker of cardiovascular disease in asymptomatic type 2 diabetes patients. Diabetes Vasc Dis Res. 2014;11(6):448\u201350. https:\/\/doi.org\/10.1177\/1479164114544464.","journal-title":"Diabetes Vasc Dis Res"},{"issue":"10","key":"2291_CR29","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.2337\/dc12-2165","volume":"36","author":"IJ Riphagen","year":"2013","unstructured":"Riphagen IJ, Boertien WE, Alkhalaf A, Kleefstra N, Gansevoort RT, Groenier KH, et al. Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular and all-cause mortality in patients with type 2 diabetes (ZODIAC-31). Diabetes Care. 2013;36(10):3201\u20137. https:\/\/doi.org\/10.2337\/dc12-2165.","journal-title":"Diabetes Care"},{"issue":"2","key":"2291_CR30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1136\/heartjnl-2015-308183","volume":"102","author":"I Tasevska","year":"2016","unstructured":"Tasevska I, Enhorning S, Persson M, Nilsson PM, Melander O. Copeptin predicts coronary artery disease cardiovascular and total mortality. Heart. 2016;102(2):127\u201332. https:\/\/doi.org\/10.1136\/heartjnl-2015-308183.","journal-title":"Heart"},{"key":"2291_CR31","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.atherosclerosis.2021.10.012","volume":"338","author":"F Schill","year":"2021","unstructured":"Schill F, Persson M, Engstr\u00f6m G, Melander O, Enh\u00f6rning S. Copeptin as a marker of atherosclerosis and arteriosclerosis. Atherosclerosis. 2021;338:64\u20138. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.10.012.","journal-title":"Atherosclerosis"},{"issue":"4","key":"2291_CR32","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1373\/clinchem.2012.193656","volume":"59","author":"B Kollerits","year":"2013","unstructured":"Kollerits B, Sturm G, Lamina C, Hammerer-Lercher A, Rantner B, Stadler M, et al. Comparison and evaluation of cardiac biomarkers in patients with intermittent claudication: results from the CAVASIC study. Clin Chem. 2013;59(4):692\u2013702. https:\/\/doi.org\/10.1373\/clinchem.2012.193656.","journal-title":"Clin Chem"},{"issue":"6","key":"2291_CR33","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1080\/1354750x.2019.1631886","volume":"24","author":"S Fatemi","year":"2019","unstructured":"Fatemi S, Acosta S, Gotts\u00e4ter A, Melander O, Engstr\u00f6m G, Dakhel A, et al. Copeptin, B-type natriuretic peptide and cystatin C are associated with incident symptomatic PAD. Biomarkers. 2019;24(6):615\u201321. https:\/\/doi.org\/10.1080\/1354750x.2019.1631886.","journal-title":"Biomarkers"},{"issue":"4","key":"2291_CR34","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/ajh.2009.8","volume":"22","author":"M Khaleghi","year":"2009","unstructured":"Khaleghi M, Saleem U, Morgenthaler NG, Turner ST, Bergmann A, Struck J, et al. Plasma midregional pro-atrial natriuretic peptide is associated with blood pressure indices and hypertension severity in adults with hypertension. Am J Hypertens. 2009;22(4):425\u201331. https:\/\/doi.org\/10.1038\/ajh.2009.8.","journal-title":"Am J Hypertens"},{"issue":"4","key":"2291_CR35","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1161\/hypertensionaha.114.03282","volume":"64","author":"S Laurent","year":"2014","unstructured":"Laurent S, Boutouyrie P. Dose-dependent arterial destiffening and inward remodeling after olmesartan in hypertensives with metabolic syndrome. Hypertens (Dallas Tex: 1979). 2014;64(4):709\u201316. https:\/\/doi.org\/10.1161\/hypertensionaha.114.03282.","journal-title":"Hypertens (Dallas Tex: 1979)"},{"issue":"4","key":"2291_CR36","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1152\/physrev.00003.2017","volume":"97","author":"P Lacolley","year":"2017","unstructured":"Lacolley P, Regnault V, Segers P, Laurent S. Vascular smooth muscle cells and arterial stiffening: relevance in Development, Aging, and Disease. Physiol Rev. 2017;97(4):1555\u2013617. https:\/\/doi.org\/10.1152\/physrev.00003.2017.","journal-title":"Physiol Rev"},{"issue":"9","key":"2291_CR37","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1007\/s11906-018-0876-9","volume":"20","author":"G Jia","year":"2018","unstructured":"Jia G, Aroor AR, Martinez-Lemus LA, Sowers JR. Potential role of antihypertensive medications in preventing excessive arterial stiffening. Curr Hypertens Rep. 2018;20(9):76. https:\/\/doi.org\/10.1007\/s11906-018-0876-9.","journal-title":"Curr Hypertens Rep"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-024-02291-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-024-02291-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-024-02291-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T15:02:32Z","timestamp":1718204552000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-024-02291-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,12]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2291"],"URL":"https:\/\/doi.org\/10.1186\/s12933-024-02291-2","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,12]]},"assertion":[{"value":"26 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Regional Ethical Review Board approved the study. Informed consent was obtained from the patients. The study protocol adhered to the principles expressed in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"200"}}